125
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis

, , , , , , , , , , , & show all
Pages 3737-3751 | Published online: 09 Aug 2016

References

  • HarveyHACreamLRBiology of bone metastases: causes and consequencesClin Breast Cancer20077Suppl 1S7S1317683652
  • LiSPengYWeinhandlEDEstimated number of prevalent cases of metastatic bone disease in the US adult populationClin Epidemiol20124879322570568
  • LiedeAJerzakKJHernandezRKWadeSWSunPNarodSAThe incidence of bone metastasis after early-stage breast cancer in CanadaBreast Cancer Res Treat201615658759527083181
  • SheaJMillerSSkeletal function and structure: implications for tissue-targeted therapeuticsAdv Drug Deliver Rev200557945957
  • BergmannRMeckelMKubicekV177Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatmentEJNMMI Res20166526780082
  • YewleJNPuleoDABachasLGBifunctional bisphosphonates for delivering PTH (1 – 34) to bone mineral with enhanced bioactivityBiomaterials2013343141314923369219
  • YangYBhadariKHPanahifarADoschakMRSynthesis, characterization and biodistribution studies of 125I-radioiodinated di-PEGylated bone targeting salmon calcitonin analogue in healthy ratsPharm Res2013311146115724357414
  • AnadaTTakedaYHondaYSakuraiKSuzukiOSynthesis of calcium phosphate-binding liposome for drug deliveryBioorg Med Chem Lett2009194148415019523821
  • FarbodKDibaMZinkevichTGelatin nanoparticles with enhanced affinity for calcium phosphateMacromol Biosci20161671772926773715
  • SwamiAReaganMRBastoPEngineered nanomedicine for myeloma and bone microenvironment targetingProc Natl Acad Sci U S A2014111102871029224982170
  • RoelofsAThompsonKGordonSRogersMMolecular mechanisms of action of bisphosphonates: current statusClin Cancer Res2006126222s6230s17062705
  • FerreiraDLopesSFrancoMOliveiraMpH-sensitive liposomes for drug delivery in cancer treatmentTher Deliv201341099112324024511
  • TorchilinVMultifunctional and stimuli-sensitive nanoparticulate system for drug deliveryNat Rev Drug Discov20141381382725287120
  • BanghamAStandishMWatkinsJDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol1965132382555859039
  • BarenholzYLiposome application: problems and prospectsCurr Opin Colloid Interface Sci200166677
  • AnanchenkoGNovakovicJTikhomirovaAAlendronate sodiumBrittainHGProfiles of Drug Substances, Excipients, and Related Methodology38San DiegoElsevier2013134
  • ChmelíkMValkovičLWolfPPhosphatidylcholine contributes to in vivo 31P MRS signal from the human liverEur Radiol2015252059206625576233
  • KlykovOWellerMGQuantification of N-hydroxysuccinimide and N-hydroxysulfosuccinimide by hydrophilic interaction chromatography (HILIC)Anal Methods2015764436448
  • PattniBSChupinVVTorchilinVPNew developments in liposomal drug deliveryChem Rev2015115109381096626010257
  • BolkesteinMde BloisEKoelewijnSJInvestigation of factors determining the enhanced permeability and retention effect in subcutaneous xenograftsJ Nucl Med20165760160726719375
  • MaedaHTsukigawaKFangJA retrospective 30 years after discovery of the enhanced permeability and retention effect of solid tumors: next-generation chemotherapeutics and photodynamic therapy problems, solutions, and prospectsMicrocirculation20162317318226237291
  • KanazakiKSanoKMakinoAFeasibility of poly(ethylene glycol) derivatives as diagnostic drug carriers for tumor imagingJ Control Release201622611512326869546
  • AlanneAHyvönenHLahtinenMSystematic study of the physicochemical properties of a homologous series of aminobisphosphonatesMolecules201217109281094522971579
  • LasicDNovel applications of liposomesTrends Biotechnol1998163073219675915
  • NegreiraNMastroianniNAldaMLBarcelóDMultianalyte determination of 24 cytostatics and metabolites by liquid chromatography-electrospray-tandem mass spectrometry and study of their stability and optimum storage conditions in aqueous solutionTalanta201311629029924148406
  • ShibataHYomotaCKawanishiTOkudaHPolyethylene glycol prevents in vitro aggregation of slightly negatively-charged liposomes induced by heparin in the presence of bivalent ionsBiol Pharm Bull20063320812087
  • JohnssonMEdwardsKLiposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipidsBiophys J2003853839384714645073
  • LopesSCNovaisMVTeixeiraCSPreparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acidBiomed Res Int2013201346714723984367
  • LopesSCNovaisMVFerreiraDSUrsolic acid incorporation does not prevent the formation of a non-lamellar phase in pH-sensitive and long-circulating liposomesLangmuir201430150831509025490253
  • SilvaSMCoelhoLNMalachiasAStudy of the structural organization of cyclodextrin-DNA complex loaded anionic and pH-sensitive liposomesChem Phys Lett20115066670
  • GarbuzenkoOBarenholzYPrievAEffect of grafted PEG on liposome size and on compressibility and packing of lipid bilayerChem Phys Lipids200513511712915921973
  • VargaZWachaAVainioUGummelJBótaACharacterization of the PEG layer of sterically stabilized liposomes: a SAXS studyChem Phys Lipids201216538739222227108
  • SongYHuangZSongYThe application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradientInt J Nanomedicine201493611362125120359
  • Rudnick-GlickSCorem-SalkmonEGrinbergIYehudaRMargelSNear IR fluorescent conjugated poly(ethylene glycol) bisphosphonate nanoparticles for in vivo bone targeting in a young mouse modelJ Nanobiotechnology2015138026577112
  • RawatPManglaniKGuptaSDesign and development of bioceramic based functionalized PLGA nanoparticles of risendronate for bone targeting: in-vitro characterization and pharmacodynamics evaluationPharm Res2015323149315825840949
  • PignatelloRSarpietroMCastelliFSynthesis and biological evaluation of a new polymeric conjugate and nanocarrier with osteotropic propertiesJ Funct Biomater20123799924956517
  • SimõesSOn the formulation of pH-sensitive liposomes with long circulation timesAdv Drug Deliv Rev20045694796515066754
  • GoormaghtighEHuartPPraetMBrasseurRRuysschaertJMStructure of the adriamycin-cardiolipin complex: role in mitochondrial toxicityBiophys Chem1990352472572204444
  • SchlameMRuaDGreenbergMLThe biosynthesis and functional role of cardiolipinProg Lipid Res20003925728810799718
  • JúniorADMotaLGNunanEATissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing miceLife Sci20078065966417141809
  • UlrichASBiophysical aspects of using liposomes as delivery vehiclesBiosci Rep20027212915012428898
  • FerreiraDSBorattoFACardosoVNAlendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitisInt J Nanomedicine2015102441245025848262